DexCom, Inc. (NASDAQ: DXCM) reported Q2 EPS of ($0.11), $0.01 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $21.4 million versus the consensus estimate of $20.83 million.

Earnings